Ilya Sedliarou Email & Phone Number | Ilya is a Group Lead at EnGeneIC Ltd and has 14 years of drug discovery and antibody engineering experience, where he developed, characterized and manufactured a bispecific antibody for drug-delivery. His work covers research, translational and regulatory areas to move a product through various phases of drug development. He supervised several key antibody projects, some of which entered the clinic in USA and Australia (clinical trial identifiers NCT02766699, NCT02687386, NCT02369198). In this role, Ilya also collaborates with major external biotechnology, CMO and academic partners. He obtained his PhD degree in Molecular Biology from Atomic Bomb Diseases Institute in Japan and a Medical Degree from Gomel State Medical University. Specialties: Recombinant Proteins, Assay Development, Antibody Engineering, Molecular Biology, Immunology, Pre-clinical, Biochemistry, Drug Discovery, GMP

Ilya Sedliarou

Ilya is a Group Lead at EnGeneIC Ltd and has 14 years of drug discovery and antibody engineering exp...
Engeneic, 2/25 Sirius Rd, Australia

*50 free lookup(s) per month.

Ilya Sedliarou’s Email isedliarou@engeneic.com

Ilya Sedliarou’s Phone Numbers

Get ILYA’s Phone Number (For Free)

Social Media

Ilya Sedliarou’s Location Engeneic, 2/25 Sirius Rd, Australia

Ilya Sedliarou’s Current Industry Engeneic

Ilya Sedliarou’s Prior Industry Nagasaki University | Gomel State Medical University

Find accurate emails & phone numbers for over 700M professionals.

Group Lead

2014-12-01 00:00:00 - Present

PHD Fellow

2003-04-01 00:00:00 - 2007-08-01 00:00:00

Clincal Pathologist

2001-09-01 00:00:00 - 2003-03-01 00:00:00

No Skills Available

No Languages Available

Ilya Sedliarou is a Ilya is a Group Lead at EnGeneIC Ltd and has 14 years of drug discovery and antibody engineering experience, where he developed, characterized and manufactured a bispecific antibody for drug-delivery. His work covers research, translational and regulatory areas to move a product through various phases of drug development. He supervised several key antibody projects, some of which entered the clinic in USA and Australia (clinical trial identifiers NCT02766699, NCT02687386, NCT02369198). In this role, Ilya also collaborates with major external biotechnology, CMO and academic partners. He obtained his PhD degree in Molecular Biology from Atomic Bomb Diseases Institute in Japan and a Medical Degree from Gomel State Medical University. Specialties: Recombinant Proteins, Assay Development, Antibody Engineering, Molecular Biology, Immunology, Pre-clinical, Biochemistry, Drug Discovery, GMP